Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN3284 |
8-Hydroxyodoroside A
|
Others | Others |
An antitumor agent containing at least one compound selected from the group consisting of nerigoside, oleandrigenin, sarmentoside, oleaside A, oleandrin, 8β-hydroxy odoroside A, narciclasine, trans-dihydronarciclasine and bisdeoxynarciclasine is provided, this antitumor agent has an advantage of having an excellent therapeutic effect of tumor and less side effects. |